73 related articles for article (PubMed ID: 553144)
1. Some genetic considerations for the design of better mammalian assay systems for the detection of chemical mutagens and carcinogens.
Wolff GL
J Environ Pathol Toxicol; 1977; 1(2):79-90. PubMed ID: 553144
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity of environmental agents assessed by the alkaline comet assay.
Møller P
Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
4. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
[TBL] [Abstract][Full Text] [Related]
5. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
6. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
7. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
8. 11th Alexander Hollaender course in genetic toxicology University of Bío-Bío, Concepcion, Chile,October 2006. Preface.
Zamorano-Ponce E
Mutat Res; 2008; 658(3):153. PubMed ID: 18456543
[No Abstract] [Full Text] [Related]
9. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
[TBL] [Abstract][Full Text] [Related]
10. [Evolution of industrial toxicology toward vanishing doses and the human genome].
Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
[TBL] [Abstract][Full Text] [Related]
11. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance.
Zeiger E
Regul Toxicol Pharmacol; 1998 Oct; 28(2):85-95. PubMed ID: 9927558
[TBL] [Abstract][Full Text] [Related]
12. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
Benigni R
J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
[TBL] [Abstract][Full Text] [Related]
13. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
14. Use of genetic toxicology information for risk assessment.
Dearfield KL; Moore MM
Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
[TBL] [Abstract][Full Text] [Related]
15. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
Bignold LP
Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
[TBL] [Abstract][Full Text] [Related]
16. Can systems toxicology identify common biomarkers of non-genotoxic carcinogenesis?
Plant N
Toxicology; 2008 Dec; 254(3):164-9. PubMed ID: 18674585
[TBL] [Abstract][Full Text] [Related]
17. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
Butterworth BE
Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
[TBL] [Abstract][Full Text] [Related]
18. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
19. Statistical design of toxicity assays: role of genetic structure of test animal population.
Haseman JK; Hoel DG
J Toxicol Environ Health; 1979 Jan; 5(1):89-101. PubMed ID: 423309
[TBL] [Abstract][Full Text] [Related]
20. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
